Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Restrictive Transfusion StratEgy Adjusted by SvO2 During Cardiac Surgery: Multicenter, Single-blinded, Randomised Controlled Trial.

NCT05740059 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT05740059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05740059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Restrictive Transfusion StratEgy Adjusted by SvO2 During Cardiac Surgery: Multicenter, Single-blinded, Randomised Controlled Trial.
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Completed
Start date
March 14, 2023
Completion date
October 21, 2025
Enrollment
676 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac surgery, cardiopulmonary bypass